Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 9NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Gastrointestinal Stromal Tumors 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Chronic-Phase 6Leukemia 6Blast Crisis 5Sarcoma 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Accelerated Phase 3Carcinoma, Ovarian Epithelial 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Polycythemia Vera 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Meningioma 2Melanoma 2Leukemia, Biphenotypic, Acute 2Fibrosarcoma 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Seminoma 1Sarcoma, Synovial 1

Interventions

Carboplatin 41Cisplatin 38Paclitaxel 34Specimen Handling 32Radiotherapy 27Magnetic Resonance Spectroscopy 25Gemcitabine 23Vinorelbine 15Etoposide 15Docetaxel 15Biopsy 13Pemetrexed 10Cyclophosphamide 10pembrolizumab 9Taxes 9Immunoglobulin G 9Disulfides 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8X-Rays 7Vinblastine 7Erlotinib Hydrochloride 7osimertinib 6durvalumab 6atezolizumab 6Nivolumab 6Irinotecan 6Ifosfamide 6Chemotherapy, Adjuvant 6Celecoxib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lung Neoplasms × Imatinib Mesylate × Clear all
NCT00045604 2008-07-24

Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡